New products about which extravagant claims are made seldom live up to their press releases – and then there’s the new drug: KYBELLA. It’s changing the field of facial and cosmetic surgery, treating a problem which bothers more adults than not, but for which there has been little treatment to offer. In April, 2015, the United States Food and Drug Administration approved the new drug for the treatment of submental fat (double chin).
KYBELLA is identical to deoxycholic acid, a substance the body produces naturally, to aid in the digestion of fats consumed in the diet. Kybella is a “cytolytic” drug that destroys the structure of cells. Prior to Kybella, facial liposuction was the only treatment available for double chins.